We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.
GNCA

Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

41 hedge funds and large institutions have $38.9M invested in Genocea Biosciences, Inc. in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

256% more call options, than puts

Call options by funds: $313K | Put options by funds: $88K

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

3% more funds holding

Funds holding: 40 → 41 (+1)

40% less capital invested

Capital invested by funds: $65.3M → $38.9M (-$26.4M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
41
Holders Change
+1
Holders Change %
+2.5%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
6
Increased
7
Reduced
6
Closed
4
Calls
$313K
Puts
$88K
Net Calls
+$225K
Net Calls Change
-$23K

Top Buyers

Rank Fund Capital Flow
1
Simplex Trading
Simplex Trading
Illinois
+$46.2K
2
Renaissance Technologies
Renaissance Technologies
New York
+$41K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$32.4K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$31.2K
5
Northern Trust
Northern Trust
Illinois
+$21.4K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$270K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$179K
3
Two Sigma Investments
Two Sigma Investments
New York
-$111K
4
Citadel Advisors
Citadel Advisors
Florida
-$86.9K
5
Group One Trading
Group One Trading
Illinois
-$26.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$12M – – –
ACA
2
Avoro Capital Advisors
New York
$5.9M – – –
BI
3
BVF Inc
California
$4.65M – – –
CC
4
Commodore Capital
New York
$3.57M – – –
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$3.08M – – –
KCM
6
Kingdon Capital Management
New York
$2.29M – – –
Citadel Advisors
7
Citadel Advisors
Florida
$2.08M -$86.9K -58,331 -3%
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.83M +$17.6K +11,778 +0.8%
BC
9
Boxer Capital
California
$1.32M – – –
AICPI
10
ABG Innovation Capital Partners III
Hong Kong
$435K – – –
HighTower Advisors
11
HighTower Advisors
Illinois
$246K – – –
Geode Capital Management
12
Geode Capital Management
Massachusetts
$239K +$31.2K +20,938 +11%
Millennium Management
13
Millennium Management
New York
$228K -$270K -180,912 -48%
IC
14
Ikarian Capital
Texas
$228K – – –
BlackRock
15
BlackRock
New York
$215K +$6.63K +4,452 +2%
Northern Trust
16
Northern Trust
Illinois
$82K +$21.4K +14,368 +25%
Bank of America
17
Bank of America
North Carolina
$67K +$40 +27 +0%
Group One Trading
18
Group One Trading
Illinois
$51K -$26.2K -17,600 -29%
Commonwealth Equity Services
19
Commonwealth Equity Services
Massachusetts
$37K +$15.8K +10,576 +49%
Simplex Trading
20
Simplex Trading
Illinois
$35K +$46.2K +31,015 New
Renaissance Technologies
21
Renaissance Technologies
New York
$32K +$41K +27,500 New
Two Sigma Advisers
22
Two Sigma Advisers
New York
$26K -$179K -119,800 -84%
Acadian Asset Management
23
Acadian Asset Management
Massachusetts
$25K +$32.4K +21,741 New
BFM
24
Boothbay Fund Management
New York
$23K – – –
State Street
25
State Street
Massachusetts
$23K – – –
1
2

GNCA Hedge Fund Activity: Q4 2021 in Review

41 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q4 2021, worth a combined $38.9M — down 40% from $65.3M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new GNCA positions and 4 closed out — a net gain of 2 holders — while 7 added to existing stakes and 6 trimmed.

The largest buyer was Simplex Trading, opening a new position worth an estimated $46.2K. The largest seller was Millennium Management, cutting an estimated $270K.

  • 41 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q4 2021, up from 40 in Q3 2021.
  • Funds reported $38.9M of Genocea Biosciences, Inc. stock for Q4 2021, down 40% quarter-over-quarter.
  • 6 funds opened new Genocea Biosciences, Inc. positions in Q4 2021 and 4 closed out, a net change of +2 holders.
  • The largest Genocea Biosciences, Inc. buyer in Q4 2021 was Simplex Trading, an estimated $46.2K added.
  • The largest Genocea Biosciences, Inc. seller in Q4 2021 was Millennium Management, an estimated $270K sold.

Based on aggregated 13F filings for Q4 2021.